[go: up one dir, main page]

MX9301879A - Medicamento para el tratamiento de la inflamacion de las vias respiratorias - Google Patents

Medicamento para el tratamiento de la inflamacion de las vias respiratorias

Info

Publication number
MX9301879A
MX9301879A MX9301879A MX9301879A MX9301879A MX 9301879 A MX9301879 A MX 9301879A MX 9301879 A MX9301879 A MX 9301879A MX 9301879 A MX9301879 A MX 9301879A MX 9301879 A MX9301879 A MX 9301879A
Authority
MX
Mexico
Prior art keywords
respiratory tract
inflammation
treatment
medication
medicament
Prior art date
Application number
MX9301879A
Other languages
English (en)
Inventor
Barbara Anne Spicer
Stephen Gerard Taylor
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9301879A publication Critical patent/MX9301879A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Esta invención se relaciona con el uso novedoso, en particular un uso para a manufactura de un medicamento para el tratamiento de la inflamación de las vías respiratorias y, en particular la hipersensibilidad de las vías respiratorias.
MX9301879A 1992-04-02 1993-04-01 Medicamento para el tratamiento de la inflamacion de las vias respiratorias MX9301879A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929207400A GB9207400D0 (en) 1992-04-02 1992-04-02 Novel use

Publications (1)

Publication Number Publication Date
MX9301879A true MX9301879A (es) 1993-12-01

Family

ID=10713459

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301879A MX9301879A (es) 1992-04-02 1993-04-01 Medicamento para el tratamiento de la inflamacion de las vias respiratorias

Country Status (11)

Country Link
EP (1) EP0633778A1 (es)
JP (1) JPH07505381A (es)
KR (1) KR950700737A (es)
AU (1) AU3765193A (es)
CA (1) CA2133470A1 (es)
GB (1) GB9207400D0 (es)
HU (1) HUT75702A (es)
IL (1) IL105233A0 (es)
MX (1) MX9301879A (es)
WO (1) WO1993019755A1 (es)
ZA (1) ZA932303B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
AU2003289207A1 (en) * 2002-12-06 2004-06-30 Kyowa Hakko Kogyo Co., Ltd. Anti-inflammatory agent
JP4976134B2 (ja) 2003-10-01 2012-07-18 アドラー コーポレーション スピロ環複素環誘導体及びそれらを使用する方法
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US9982010B2 (en) 2014-04-07 2018-05-29 Women & Infants Hospital Of Rhode Island 7-dehydrocholesterol derivatives and methods using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86798A (en) * 1987-06-23 1992-12-01 Sanofi Sa 2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them
IL88035A0 (en) * 1987-10-27 1989-06-30 American Home Prod Benzopyran derivatives,their preparation and pharmaceutical compositions containing them
ES2071668T3 (es) * 1988-12-13 1995-07-01 Beecham Group Plc Benzopirano y compuestos relacionados.
GB2242628A (en) * 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators

Also Published As

Publication number Publication date
HU9402816D0 (en) 1994-12-28
WO1993019755A1 (en) 1993-10-14
IL105233A0 (en) 1993-07-08
JPH07505381A (ja) 1995-06-15
EP0633778A1 (en) 1995-01-18
ZA932303B (en) 1994-06-06
KR950700737A (ko) 1995-02-20
GB9207400D0 (en) 1992-05-13
CA2133470A1 (en) 1993-10-14
AU3765193A (en) 1993-11-08
HUT75702A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
ES2177780T3 (es) Medicamentos para el tratamiento de enfermedades autoinmunes usando interferon tau.
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
ES2164097T3 (es) Uso de anestesicos topicos para la fabricacion de un medicamento para el tratamiento del asma bronquial.
BR1100860A (pt) Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto
IS3959A (is) Aðferð við framleiðslu á blöndu sem samanstendur af lyfi sem er berkjuvíkkandi og bólgueyðandi steralyfi til meðhöndlunar á öndunartruflunum og notkun hennar
IT1254517B (it) 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
DE69129248D1 (de) Peptide mit Endothelin antagonistischer Aktivität, deren Herstellung und pharmazeutische Zusammensetzungen
AR002261A1 (es) Composicion en polvo para la administracion por inhalacion de polipeptidos utiles en medicina, metodos para la manufactura de dicha composicion, y uso de la composicion para la manufactura de un medicamento para el tratamietno de enfermedades a traves del tracto respiratorio
MX9305934A (es) Nuevo modificador de resistencia a drogas multiples.
ES2188651T3 (es) Guanilhidrazonas para el tratamiento de afecciones inflamatorias.
AR015257A1 (es) UNA COMPOSICION ACIDIFICADA Y EL USO DE DICHA COMPOSICION PARA LA MANUFACTURA DE UN MEDICAMENTO PARA EL TRATAMIENTO ToPICO DE CONDICIONES DE LAS UNAS Y DE LA PIEL
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
AR003984A1 (es) Composiciones antipruriticas, cosmeticas y/o farmaceuticas, procedimiento para su preparacion y empleo de dichas composiciones para la obtencion de unmedicamento.
ITRM920270A0 (it) Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
ES2061989T3 (es) Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
MX9301879A (es) Medicamento para el tratamiento de la inflamacion de las vias respiratorias
MX9300558A (es) Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene.
ES2188611T3 (es) Empleo de granisetron para el tratamiento de las nauseas y vomitos postoperatorios.
ES2150547T3 (es) Uso de dimeticona para la fabricacion de un medicamento para el tratamiento de aftas y estomatitis.
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ES2181915T3 (es) Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
ES2058349T3 (es) Utilizacion de betabloqueadores para el tratamiento de la progresion de la miopia axial infantil.